Contractile dysfunction in a mouse model expressing a heterozygous MYBPC3 mutation associated with hypertrophic cardiomyopathy.
about
Epigallocatechin-3-Gallate Accelerates Relaxation and Ca2+ Transient Decay and Desensitizes Myofilaments in Healthy and Mybpc3-Targeted Knock-in Cardiomyopathic Mice.Surviving the infarct: A profile of cardiac myosin binding protein-C pathogenicity, diagnostic utility, and proteomics in the ischemic myocardium.A hypertrophic cardiomyopathy-associated MYBPC3 mutation common in populations of South Asian descent causes contractile dysfunctionConstitutive phosphorylation of cardiac myosin regulatory light chain prevents development of hypertrophic cardiomyopathy in miceOxidative Stress in Dilated Cardiomyopathy Caused by MYBPC3 Mutation.Haploinsufficiency of MYBPC3 exacerbates the development of hypertrophic cardiomyopathy in heterozygous mice.Proteomic analysis of physiological versus pathological cardiac remodeling in animal models expressing mutations in myosin essential light chains.Alterations in Multi-Scale Cardiac Architecture in Association With Phosphorylation of Myosin Binding Protein-C.Gene expression patterns in transgenic mouse models of hypertrophic cardiomyopathy caused by mutations in myosin regulatory light chain.The genetic landscape of cardiomyopathy and its role in heart failure.The naked mole-rat exhibits an unusual cardiac myofilament protein profile providing new insights into heart function of this naturally subterranean rodent.The genetic basis of hypertrophic cardiomyopathy in cats and humans.The Role of Cardiac Myosin Binding Protein C3 in Hypertrophic Cardiomyopathy-Progress and Novel Therapeutic Opportunities.Cardiac inflammation in genetic dilated cardiomyopathy caused by MYBPC3 mutation.Selective phosphorylation of PKA targets after β-adrenergic receptor stimulation impairs myofilament function in Mybpc3-targeted HCM mouse model.Nebivolol Desensitizes Myofilaments of a Hypertrophic Cardiomyopathy Mouse Model.Cardiac troponin I tyrosine 26 phosphorylation decreases myofilament Ca2+ sensitivity and accelerates deactivation.Sexual dimorphic response to exercise in hypertrophic cardiomyopathy-associated MYBPC3-targeted knock-in mice.Genetic Pathogenesis of Hypertrophic and Dilated Cardiomyopathy.
P2860
Q30830714-05BF1E4E-3BA2-4550-84FE-185DB420DF25Q34172185-E0E45B06-2A9B-4DC5-A3FD-7213E48EDAC6Q35126714-97E65E44-B18A-4EC9-81BA-75A1C55ADCE4Q35910163-1A10AB74-E9B1-42F2-90AA-6BF712F69377Q36174383-D67BC892-1B1C-45BD-AD51-E5A34C4C62EEQ36272676-84FDD10A-51A9-4569-AEEC-E1815776965AQ36843579-3B649A59-1BAF-4EA6-808A-A7C4FC812028Q37090787-D6633FEF-7242-4D9A-AB48-0C841337F0E6Q37726526-485D6394-71ED-4895-96E1-68CCCFA770E7Q38343935-F2FD7DEA-9590-4A65-AE3F-1EDE674B3BB7Q38638631-02F6B3DA-720F-4617-BD0E-BB4968B4C8D9Q38699748-7051BA3E-41EF-4443-9B11-1D933AACDBE2Q38978665-2AAFB297-8231-4C77-893B-87B50E1D1DE7Q39107858-BA9614C0-499E-4674-933D-B6FB026C2AF2Q40042653-D3C07965-9E50-4705-998C-1F8BAC196986Q41203153-EEABF73A-81C4-4ECF-A7D1-BF7758FAC8DEQ42264504-352F9FEE-C676-4629-A2BB-05B2F48C9155Q51128798-73B8AACA-E976-45AC-8267-06D41AE84FE6Q52662539-B17B2DF3-1556-413F-A760-923D52744A08
P2860
Contractile dysfunction in a mouse model expressing a heterozygous MYBPC3 mutation associated with hypertrophic cardiomyopathy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Contractile dysfunction in a m ...... h hypertrophic cardiomyopathy.
@en
Contractile dysfunction in a m ...... h hypertrophic cardiomyopathy.
@nl
type
label
Contractile dysfunction in a m ...... h hypertrophic cardiomyopathy.
@en
Contractile dysfunction in a m ...... h hypertrophic cardiomyopathy.
@nl
prefLabel
Contractile dysfunction in a m ...... h hypertrophic cardiomyopathy.
@en
Contractile dysfunction in a m ...... h hypertrophic cardiomyopathy.
@nl
P2860
P50
P1476
Contractile dysfunction in a m ...... h hypertrophic cardiomyopathy.
@en
P2093
Pieter P de Tombe
P2860
P304
P356
10.1152/AJPHEART.00913.2013
P577
2014-01-24T00:00:00Z